Stage of HIV presentation at initial clinic visit following a community-based HIV testing campaign in rural Kenya by Haskew, John et al.
Haskew et al. BMC Public Health  (2015) 15:16 
DOI 10.1186/s12889-015-1367-4RESEARCH ARTICLE Open AccessStage of HIV presentation at initial clinic visit
following a community-based HIV testing
campaign in rural Kenya
John Haskew1*, Kenrick Turner2, Gunnar Rø1,3, Andrew Ho4, Davies Kimanga5 and Shahnaaz Sharif6Abstract
Background: The Kenyan Ministry of Health and partners implemented a community-based integrated prevention
campaign (IPC) in Western Kenya in 2008. The aim of this study was to determine whether the IPC, compared to
Voluntary Counselling and Testing (VCT) services, was able to identify HIV positive individuals earlier in the clinical
course of HIV infection following testing.
Methods: A total of 1,752 adults aged over 15 years who tested HIV positive through VCT services or the IPC, and
subsequently registered at initial clinic visit between September 2008 and September 2010, were considered in the
analysis. Multivariable logistic regression models were developed to assess the association of CD4 count and WHO
clinical stage of HIV infection at first clinic appointment with age group, gender, marital status and HIV testing source.
Results: Male gender and marital status were independently associated with late HIV presentation (WHO clinical stage
3 or 4 or CD4 count ≤350 cells/μl) at initial clinic visit. Patients testing HIV positive during the IPC had significantly
higher mean CD4 count at initial clinic visit compared to individuals who tested HIV positive via VCT services. Patients
testing HIV positive during the IPC had more than two times higher odds of presenting early with CD4 count greater
than 350 cells/μl (adjusted OR 2.15, 95% CI 1.28 – 3.61, p = 0.004) and presenting early with WHO clinical stage 1 or 2
of HIV infection (adjusted OR 2.39, 95% CI 1.24 – 4.60, p = 0.01) at initial clinic visit compared to individuals who tested
HIV positive via VCT services.
Conclusion: The community-based integrated prevention campaign identified HIV positive individuals earlier in the
course of HIV infection, compared to Voluntary Counselling and Testing services. Community-based campaigns, such as
the IPC, may be able to assist countries to achieve earlier testing and initiation of ART in the course of HIV infection.
Improving referral mechanisms and strengthening linkages between HIV testing and treatment services remain a
challenge and electronic medical record (EMR) systems may support monitoring of patients throughout the HIV care
and treatment continuum.
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Linkage to careBackground
The Joint United Nations Programme on HIV/AIDS
(UNAIDS) estimates 35.3 million people worldwide are
living with HIV, with an estimated 2.3 million new infec-
tions in 2012 [1]. The epidemic continues to dispropor-
tionately affect sub-Saharan Africa, which is home to
70% of all new HIV infections [1]. Knowledge of HIV* Correspondence: john.haskew@uamuzibora.org
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unless otherwise stated.status remains inadequate, despite significant scaling up
of HIV testing services over the past decade [1]. In 2011,
an estimated 36% of people in the region had never been
tested for HIV and less than 50% of people living with
HIV in sub-Saharan Africa knew their status [1,2].
Due to the lack of access to HIV testing services, an
estimated 25% of people who initiate ART in low- and
middle-income countries have CD4 counts <100 cells/μl,
and late stage of HIV presentation at the time of ART
initiation is an important prognostic factor for treatment
success [3]. Patients with advanced HIV disease at thel. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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World Health Organization (WHO) clinical stage 3 or 4
of infection, are less likely to respond to treatment and
have a higher mortality rate compared with those who
start treatment earlier [4-6]. In addition, those who sur-
vive suffer more morbidity and utilise more health care
resources than would otherwise have been necessary,
placing increased financial burden on health services [7].
Late presentation also poses a higher cumulative risk of
HIV transmission to others, considering that earlier
presentation and access to ART can reduce viral load
and risk of onward transmission [6,8-10].
In an effort to increase access to HIV testing services,
and to identify people living with HIV earlier in the
course of infection, the Kenyan Ministry of Health and
partners launched a community integrated prevention
campaign (IPC) in Western Province, Kenya in September
2008 [11]. The IPC provided HIV testing and counseling
services, water filters, insecticide-treated bed nets, con-
doms, and for HIV-infected individuals cotrimoxazole
prophylaxis and referral to care. 47,311 people attended
the campaign, achieving 87% coverage among the target
population over the age of 15 years in seven days and, of
all those tested, 1,956 (4.1%) were found to be HIV posi-
tive and referred to Ministry of Health care and support
services [11].
There is a paucity of published data comparing linkage
to HIV treatment services from different sources of HIV
testing. The overall aim of this study was to determine
whether the IPC, compared to Voluntary Counselling
and Testing (VCT) services, was able to identify HIV
positive individuals earlier in the clinical course of infec-
tion, defined by CD4 count and WHO clinical stage of
HIV infection at first clinic visit.
Methods
Study population and design
Data for this study included all patients who attended
the HIV clinic of Kakamega Provincial General Hospital,
Western Kenya for their first clinic visit between January
2004 and September 2010. In 2012, HIV prevalence in
Western Kenya is 4.7%, compared to a national average
of 5.6% [12].
Data were obtained from the Uamuzi Bora Electronic
Medical Record (EMR) system [13], an open-source web-
based database that replicates information collected in the
national paper-based HIV outpatient record, which in-
cludes socio-demographic information, patient source of
testing, treatment history, and clinical and laboratory re-
sults. The EMR system was designed to enable the Minis-
try of Health to maintain accurate HIV medical records,
track patients and monitor outcomes more effectively.
Clinical and demographic data from the initial clinic
visit were extracted for use in the analysis, including age,gender, source of HIV testing, date of diagnosis, date of
first clinic appointment, clinical data from first clinic
appointment (WHO clinical stage of infection) and date
started ART. Quality control checks were performed
during data entry into the EMR database from the paper
record, during which electronic records were compared
variable by variable with the original paper record.
In September 2010, 6,657 HIV positive patients were
registered in the EMR system, including 108 adults who
tested HIV positive during the IPC and 3,651 patients
who tested HIV positive via VCT services.
Statistical analysis
All analyses were carried out using STATA version 12.1
(Stata Corp; College Station, TX). Primary outcomes
considered for analysis were CD4 count and WHO clin-
ical stage of HIV infection at initial clinic visit.
Early or late presentation of HIV (by CD4 count or
WHO clinical stage of HIV infection) was defined ac-
cording to thresholds for initiation of antiretroviral ther-
apy (ART) as indicated in the 2011 fourth edition of the
Guidelines for antiretroviral therapy in Kenya [14]. This
guideline recommends ART to be started in all HIV-
positive adults and adolescents with WHO clinical stage
1 or 2 and a CD4 count ≤ 350 cells/μl or with WHO
clinical stage 3 or 4 regardless of CD4 count. CD4 count
was coded as a numeric value at initial clinic visit and as
a binary variable, defined as early presentation (CD4 >
350 cells/μl) or late presentation (CD4 ≤ 350 cells/μl) ac-
cording to the 2011 Guidelines for antiretroviral therapy
in Kenya [14]. WHO clinical stage of HIV infection was
categorised as early presentation (stages 1 or 2) or late
presentation (stages 3 or 4) according to 2011 Guide-
lines for antiretroviral therapy in Kenya [14]. Age group,
gender, marital status and HIV testing source were
considered independent variables in the analysis.
A total of 3,759 adults testing HIV positive through VCT
services (n = 3,651) or the IPC (n = 108) were initially con-
sidered in the analysis. VCT patients prior to 1 September
2008 were excluded from analysis (n = 1,944), because the
IPC was undertaken in September 2008 and improvements
in provision of HIV testing and treatment services since
the first patients were registered at the clinic in 2004 could
bias results. All children under the age of 15 years were
also excluded from VCT services (n = 63) because the IPC
only included individuals over the age of fifteen, leaving a
total sample size of 1,752 considered for analysis (1,644
from VCT, 108 from IPC). Patients with missing data for
WHO clinical stage and CD4 count were compared to
patients with complete data using Pearson χ2 tests to
check for differences in distribution of socio-demographic
variables and to assess for the likelihood of bias.
A multivariable logistic regression model was developed
to identify independent correlates of late presentation.
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including HIV testing source and potential confounders
showing a strong association with the outcome (p < 0.1) in
univariable analysis. The variable most strongly related
(lowest p-value) to the outcome in univariable analysis
was the first to be included in the logistic regression
model. A likelihood ratio test was then carried out on the
model with and without this variable. The variable with
the next smallest P-value from the univariable analyses
was then added into the model. Variables were added until
no further variables improved the fit of the model (p >
0.05). Any variables with p > 0.05 were tested to ensure
they had no effect on the final multivariable model.
Adjusted multivariable odds ratios, 95% confidence
intervals and p-values are presented.
Ethical issues
The study was approved by the institutional review
board at Kakamega Provincial General Hospital and the
Director of Public Health, Ministry of Health, Kenya.
Results
Missing data
Of 1,752 patient records initially included in the analysis,
just over one half did not record CD4 count and one quarter
of patient records did not record WHO clinical stage on
the initial visit form (Table 1). Patients who had CD4
count and WHO clinical stage information were com-
pared with those who had none using Pearson χ2 trend
tests and significant difference (p < 0.05) was found be-
tween different patient sources of HIV testing source
(Table 1). Patients with missing CD4 count and WHOTable 1 Socio-demographic characteristics of patients with and
Characteristic N. (%) with
initial WHO stage
N. (%) missing
initial WHO stage
Pearson
Total 1,314 (75.0%) 438 (25.0%)
Patient testing source 4.263
IPC 90 (86.5%) 18 (16.7%)
VCT 1,224 (74.5%) 420 (25.5%)
Age group 1.416
50 years and under 1,106 (74.5%) 379 (25.5%)
Over 50 years 208 (77.9%) 59 (22.1%)
Gender 0.515
Female 833 (74.4%) 286 (25.6%)
Male 481 (76.0%) 152 (24.0%)
Marital status* 8.468
Married 691 (76.5%) 212 (23.5%)
Never married 125 (66.5%) 63 (33.5%)
Divorced/widowed 368 (75.6%) 119 (24.4%)
*174 missing values.clinical stage were therefore removed from subsequent
analysis when comparing IPC to VCT services (Tables 2
and 3).Descriptive analysis
Of 1,752 patients included in analysis, 108 were from
the IPC and 1,644 from VCT services. The median age
was 38.6 years (range 38.0 – 39.1 years). The sample was
nearly two-thirds female and more than half of the sam-
ple reported being married (Table 4). Nearly two-thirds
of patients presented to the clinic with CD4 ≤ 350 cells/
μl (mean CD4 304.0 cells/μl) and more than one quarter
of patients presented in WHO clinical stage 3 or 4
(Table 4).Multivariable analysis
A multivariable analysis was conducted including all
variables studied in the univariable analysis. Patients
who tested HIV positive via VCT services had more than
two times higher odds of presenting to initial clinic visit
in WHO clinical stage 3 or 4 of HIV infection than
those who tested HIV positive during the IPC (adjusted
OR 2.39, 95% CI 1.24 – 4.60, p = 0.01) (Table 2). Patients
who tested HIV positive via VCT services had more than
two times higher odds of presenting to initial clinic visit
with CD4 ≤ 350 cells/μl than those who tested HIV posi-
tive during the IPC (adjusted OR 2.15, 95% CI 1.28 –
3.61, p = 0.005) (Table 3). Mean CD4 count at initial
clinic visit among patients testing HIV positive via VCT
was significantly lower than those who tested HIV
positive during the IPC (Table 5).without initial WHO clinical stage and CD4 count recorded
χ2 P N. (%) with
initial CD4 count
N. (%) missing
initial CD4 count
Pearson χ2 P
861 (49.1%) 891 (50.9%)
0.04 14.14 0.000
72 (66.7%) 36 (33.3%)
789 (48.0%) 855 (52.0%)
0.23 0.087 0.77
732 (49.3%) 753 (50.7%)
129 (48.3%) 138 (51.7%)
0.47 1.406 0.24
538 (48.1%) 581 (51.9%)
323 (51.0%) 310 (49.0%)
0.01 1.06 0.59
444 (49.2%) 459 (50.8%)
85 (45.2%) 103 (54.8%)
240 (49.3%) 247 (50.7%)
Table 2 Socio-demographic, clinical characteristics and univariable/multivariable associations with late HIV disease
presentation (WHO clinical stage 3 or 4) at initial clinic visit
Characteristics Early presentation
(WHO stage 1/2) N. (%)*
Late presentation
(WHO stage 3/4) N. (%)*
Unadj OR (95% CI) P Adj OR^ (95% CI) P
All participants 955 (72.7%) 359 (27.3%)
HIV testing source
IPC 75 (83.3%) 15 (16.7%) 1
VCT 880 (71.9%) 344 (28.1%) 1.95 (1.11 – 3.45) 0.02 2.39 (1.24 – 4.60) 0.01
Age
50 years and under 809 (73.1%) 297 (26.9%) 1 1
Over 50 years 146 (70.2%) 62 (29.8%) 0.46 (0.28 – 0.74) 0.002 1.10 (0.77 – 1.57) 0.61
Gender
Female 623 (74.5%) 210 (25.2%) 1 1
Male 332 (69.0%) 149 (31.0%) 1.33 (1.04 – 1.71) 0.02 1.38 (1.04 – 1.83) 0.02
Marital status†
Married 524 (75.8%) 167 (24.2%) 1 1
Never married 95 (76.0%) 30 (24.0%) 0.99 (0.63 – 1.55) 0.97 1.02 (0.65 – 1.59) 0.95
Divorced/widowed 252 (68.5%) 116 (31.5%) 1.44 (1.09 – 1.91) 0.01 1.55 (1.15 – 2.08) 0.004
*Patients missing WHO stage removed from analysis (n = 438).
†130 missing values.
^Adjusted for age, gender, marital status.
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independently associated with presenting late to initial
clinic visit at WHO clinical stage 3 or 4 (Table 2). Age
over 50 years was independently associated with present-
ing late to initial clinic visit with CD4 ≤ 350 cells/μl
(Table 3).Table 3 Socio-demographic, clinical characteristics and univa
presentation (CD4 count ≤ 350 cells/μl) at initial clinic visit
Characteristics Early presentation
(CD4 > 350 cells/μl) N. (%)*
Late presentation
(CD4 ≤ 350 cells/μl)
All Participants 297 (34.5%) 564 (65.5%)
HIV Testing Source
IPC 34 (47.2%) 38 (52.8%)
VCT 263 (33.3%) 526 (66.7%)
Age
50 years and under 264 (35.3%) 468 (64.7%)
Over 50 years 33 (33.1%) 96 (66.9%)
Gender
Female 190 (51.5%) 348 (48.5%)
Male 107 (47.7%) 216 (52.3%)
Marital status†
Married 150 (33.8%) 294 (66.2%)
Never married 35 (41.2%) 50 (58.8%)
Divorced/widowed 79 (32.9%) 161 (67.1%)
*Patients missing CD4 count removed from analysis (n = 891).
†92 missing values.
^Adjusted for age, gender, marital status.Discussion
Age, gender and current marital status are all associated
with late HIV presentation (WHO clinical stage 3 or 4
or CD4 ≤ 350 cells/μl) at first clinic appointment, which
supports the findings of previous studies. Men had 1.4
times higher odds of presenting to clinic late in theriable/multivariable associations with late HIV disease
N. (%)*
Unadj OR (95% CI) P Adj OR^ (95% CI) P
1
1.79 (1.10 – 2.90) 0.002 2.15 (1.28 – 3.60) 0.005
1 1
1.64 (1.07 – 2.51) 0.002 1.72 (1.09 – 2.74) 0.02
1 1
1.10 (0.82 – 1.48) 0.51 1.01 (0.73 – 1.40) 0.94
1 1
0.73 (0.45 – 1.17) 0.19 0.71 (0.44 – 1.16) 0.17
1.04 (0.75 – 1.45) 0.82 0.96 (0.68 – 1.37) 0.83
Table 4 Socio-demographic and clinical characteristics of patients, by HIV testing source (IPC or VCT)
Characteristics IPC N. (%) VCT N. (%) Total N. (%)
All participants 108 (6.2%) 1,644 (93.8%) 1,752 (100%)
WHO clinical stage at initial clinic visit*
1 or 2 75 (7.8%) 880 (92.2%) 955 (100.0%)
3 or 4 15 (4.2%) 344 (95.8%) 359 (100.0%)
CD4 count at initial clinic visit**
>350 cells/mm3 45 (10.4%) 386 (89.6%) 431 (100.0%)
≤350 cells/mm3 27 (6.3%) 403 (93.7%) 430 (100.0%)
Mean CD4 count at initial clinic visit (cells/μl) 368.0 298.1 304.0
95% CI (cells/μl) (305.0 – 431.0) (280.1 – 316.2) (286.6 – 321.4)
Age
50 years and under 80 (5.4%) 1,405 (94.6%) 1,485 (100.0%)
Over 50 years 28 (10.5%) 239 (89.5%) 267 (100.0%)
Gender
Female 73 (6.5%) 1,046 (93.5%) 1,119 (100.0%)
Male 35 (5.5%) 598 (94.5%) 633 (100.0%)
Marital status***
Married 73 (8.1%) 830 (91.9%) 903 (100.0%)
Never married 4 (2.1%) 184 (97.9%) 188 (100.0%)
Divorced/widowed 23 (4.7%) 464 (95.3%) 487 (100.0%)
*438, **891, ***174 missing values.
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der differences have been observed in other studies with
regard to presentation to HIV clinic [15,16], as well as
general outpatient health service utilisation [17,18]. Age
over 50 years was also significantly associated with late
HIV presentation, as shown in other studies [19], which
may be due to a lack of knowledge of the disease and
services available, or a low self-perceived risk of HIV in
older age groups [9]. Increasing age has also been shown
to have a negative impact on retention in care and over-
all treatment outcomes [20]. Not being married was as-
sociated with late presentation, as reported in previous
studies [15].
More than two-thirds of patients who tested HIV posi-
tive via VCT services presented to initial clinic with CD4
≤ 350 cells/μl and one-quarter of patients who tested
HIV positive via VCT services presented to initial clinic
with WHO clinical stage 3 or 4 of HIV infection, whichTable 5 Two sample t test with equal variances comparing
mean CD4 count between IPC and VCT testing sources
HIV testing source Obs Mean CD4 count (cells/μl) (95% CI)
IPC 72 368.0 (304.0 – 432.0)
VCT 789 298.1 (280.0 – 316.2)
Total 861 304.0 (286.6 – 321.4)
t = 2.184, d.f = 859, p = 0.03.is comparable to other studies in sub-Saharan Africa
[16]. A significantly lower proportion of patients who
tested HIV positive during the community-based IPC
presented to their initial clinic visit late in the course of
infection. The IPC may have identified patients earlier in
the clinical course of HIV infection in the community
because these individuals may be asymptomatic and
have less perceived risk than those who self-attended
VCT services. Community-based campaigns of HIV test-
ing may therefore be able to reach individuals who are
unaware of their HIV status and still at an early stage of
infection. [21] While the rate of people ever having been
tested for HIV has increased in Kenya, nearly half of
people living with HIV still do not know they are infected
[12]. These individuals may not be symptomatic, may not
have adequate knowledge or understanding of HIV signs
and symptoms, and/or may have low self-perceived risk
and understanding of HIV transmission [22,23].
It is important to acknowledge the limitations of this
study. Other important potential confounders such as
socioeconomic status, HIV status of the spouse and time
required to travel to clinic were not included in the
paper-based patient record or EMR system and therefore
could not be included and adjusted for in the analysis.
Comparative analysis of the entire dataset and inclusion
of all patients testing HIV positive via VCT services was
also not possible due to missing data in the dataset.
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medical records are rarely kept up to date and complete
in sub-Saharan Africa, making their use problematic for
rigorous analysis and follow-up of outcomes [24].
During the IPC in September 2008, a significantly
higher median CD4 count was recorded at the point of
testing compared to those testing HIV positive from
the IPC at initial clinic visit during this study, suggesting
a lack of timely linkage between testing and care
[11]. Improved referral mechanisms, particularly from
community-based settings, are therefore also required to
ensure timely and accountable linkage between testing
and treatment services to ensure the gains of earlier
testing are realised [2,3,25]. Few referral tools have been
developed however and effective linkage between HIV
testing and initiation of ART remains a challenge [24,26].
Little systematic data exist on the proportion of people
living with HIV who are linked to care [26,27] and, once
linked to care, there are mixed findings regarding reten-
tion in care. In a systematic review by Rosen et al., no
study was able to follow patients from testing to treatment
if they were not already eligible for ART when diagnosed
[24]. Reasons for poor linkage between HIV testing and
treatment services are multi-factorial and include systemic
factors such as inadequate training, lack of access to
timely and reliable data (electronic or paper based) and
individual patient factors such as financial costs and prox-
imity or preference for certain health facilities [28-30].
Electronic medical record (EMR) systems could support
linkage of patients from testing to treatment services and
should be evaluated further in real-time program settings.
EMR systems may also help to improve the quality of
data collected, as well as support provision of clinical
care and ensure individuals are monitored and retained
throughout the HIV care and treatment continuum.
Conclusions
The community-based IPC identified HIV positive individ-
uals earlier in the course of HIV infection, compared to
voluntary counselling and testing services. The IPC may
have identified patients earlier in the clinical course of HIV
infection in the community because these individuals may
be asymptomatic and have less perceived risk than those
who self-attended VCT services. Such community-based
campaigns of HIV testing may be able to assist countries to
achieve earlier testing and initiation of ART in the course
of HIV infection. A significantly higher median CD4 count
was recorded at the point of testing during the IPC com-
pared to those testing HIV positive from the IPC at initial
clinic visit. Improving referral mechanisms and strength-
ening linkages between HIV testing and treatment ser-
vices remain a challenge and electronic medical record
(EMR) systems may support monitoring of patients
throughout the HIV care and treatment continuum.Competing interests
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